Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells (Q40744495)

23 September 2017

Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells (English)

1 reference

23 September 2017

1 reference

8

1 reference

23 September 2017

9

1 reference

23 September 2017

Katia Scotlandi

1

1 reference

23 September 2017

Cecilia Maini

2

1 reference

23 September 2017

Maria Cristina Manara

3

1 reference

23 September 2017

Stefania Benini

4

1 reference

23 September 2017

Massimo Serra

5

1 reference

23 September 2017

Vanessa Cerisano

6

1 reference

23 September 2017

Rosaria Strammiello

7

1 reference

23 September 2017

Patrizia Nanni

10

1 reference

23 September 2017

Giordano Nicoletti

11

1 reference

23 September 2017

Piero Picci

12

1 reference

23 September 2017

1 March 2002

1 reference

23 September 2017

1 reference

23 September 2017

9

1 reference

23 September 2017

3

1 reference

23 September 2017

296-307

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700442

23 September 2017

0 references

cites work

Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

Real time quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

A novel method for real time quantitative RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

Role of cell shape in growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

Anti-apoptotic signaling of the IGF-I receptor in fibroblasts following loss of matrix adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

Basis for the acquisition of malignant potential by mouse cells cultivated in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

Murine model for skeletal metastases of Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

Type I and type II insulin-like growth factor receptors and their function in human Ewing's sarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberrati

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

7 January 2021

Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

7 January 2021

Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

7 January 2021

Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

7 January 2021

Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

7 January 2021

Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

7 January 2021

Cell-cycle arrest versus cell death in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

7 January 2021

Effect of the insulin-like growth factor I receptor on ionizing radiation-induced cell death in mouse embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700442

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700442

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference